
In the last decade, since we first zzso that zzso zzso therapy was a promising new approach to therapy, there have been remarkable zzso zzso effects have been recognized from completely unrelated and unexpected agents, including zzso zzso therapy, zzso zzso necrosis factor, zzso zzso and zzso These vascular effects may coexist with direct zzso to the zzso cells or they may explain all of the zzso zzso In order to benefit from such vascular effects, we need to monitor them, understand their mechanisms of action and ensure that the clinical scheduling is zzso to give the greatest therapeutic zzso The biologist must re-evaluate the zzso of his or her zzso models and the zzso must question whether drugs targeted at zzso cells should be sought or whether it would be more productive to target the zzso supply through the zzso The molecular biology approaches of zzso expression in zzso cells and growth factor dependency must be weighed against zzso the zzso of the zzso mass and its supporting normal zzso zzso Since this is a highly complex field there will be many fascinating years of work zzso zzso versus normal vascular zzso In the meantime, we need to ensure that we do not reject useful therapeutic agents by inappropriate scheduling based on a misunderstanding of their mode of action, or by the use of inappropriate models for testing potential zzso zzso 

